Atul Verma, University of Ottawa

Research

Atrial Fibrillation Catheter Ablation Oral Anticoagulation Randomized Clinical Trial Stroke Prevention Cardiac Arrhythmia - Atrial Fibrillation Catheter Ablation Therapy

Latest papers

Progression of Atrial Fibrillation after Cryoablation or Drug Therapy
New England Journal of Medicine · 2023 · senior author
Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation
New England Journal of Medicine · 2021 · senior author
Real-world outcomes, complications, and cost of catheter-based ablation for atrial fibrillation: an update.
Current opinion in cardiology · 2017 · senior author

All 8 publications

Latest funding

Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation (COAST-AF) Randomized Controlled Trial
CIHR · 2020 · Principal investigator
$952,426
The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) Trial
CIHR · 2020 · Nominated PI
$956,250
The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) Trial
CIHR · 2019 · Nominated PI
$100,000

All 6 grants and awards

8 publications.

01

Progression of Atrial Fibrillation after Cryoablation or Drug Therapy

Yung D, Jolly U, Wardell S, Kochhäuser S, Deyell MW, Macle L, Wells GA, Bennett M, Essebag V, Champagne J

New England Journal of Medicine2023385 citationsSenior author

DOI: 10.1056/nejmoa2212540

02

Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation

Yung D, Jolly U, Wardell S, Andrade JG, Wells GA, Deyell MW, Bennett M, Essebag V, Champagne J, Roux J-F

New England Journal of Medicine2021795 citationsSenior authorOpen Access

DOI: 10.1056/nejmoa2029980 PMID: W3101635021

03

Real-world outcomes, complications, and cost of catheter-based ablation for atrial fibrillation: an update.

Ha AC, Wijeysundera HC, Birnie DH, Verma A

Current opinion in cardiology2017Senior author

DOI: 10.1097/hco.0000000000000348 PMID: 27755137

04

Subclinical Atrial Fibrillation in Older Patients

Healey JS, Alings M, Ha A, Leong-Sit P, Birnie DH, de Graaf JJ, Freericks M, Verma A, Wang J, Leong D

Circulation2017244 citations

DOI: 10.1161/circulationaha.117.028845

05

Long-term oral anticoagulation for patients after successful catheter ablation of atrial fibrillation: is it necessary?

Ha AC, Hindricks G, Birnie DH, Verma A

Current opinion in cardiology2015Senior author

DOI: 10.1097/hco.0000000000000121 PMID: 25389647

06

Radiographic predictors of lead conductor fracture.

Krahn AD, Morissette J, Lahm R, Haddad T, Baxter WW, McVenes R, Crystal E, Ayala-Paredes F, Cameron D, Verma A, Simpson CS, Exner DV, Birnie DH

Circulation. Arrhythmia and electrophysiology2014

DOI: 10.1161/circep.114.001612 PMID: 25262117

07

Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation

Healey JS, Wells GA, Verma A, Tang AS, Krahn AD, Simpson CS, Ayala-Paredes F, Coutu B, Leiria TLL, Essebag V

New England Journal of Medicine2013558 citations

DOI: 10.1056/nejmoa1302946

08

Clinical Predictors of Fidelis Lead Failure

Birnie DH, Parkash R, Exner DV, Essebag V, Healey JS, Verma A, Coutu B, Kus T, Mangat I, Ayala-Paredes F

Circulation2012107 citations

DOI: 10.1161/circulationaha.111.053744

Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation (COAST-AF) Randomized Controlled Trial

Principal investigatorCIHR2020Project Grant

Principal investigators: Nery, Pablo; Birnie, David H; Verma, Atul; Wells, George A

Keywords: Cardiac Arrhythmia - Atrial Fibrillation; Catheter Ablation Therapy

$952,426

The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) Trial

Nominated PICIHR2020Project Grant

Principal investigators: Verma, Atul; Birnie, David H

Keywords: Atrial Fibrillation; Catheter Ablation; Oral Anticoagulation; Randomized Clinical Trial; Stroke Prevention

$956,250

The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) Trial

Nominated PICIHR2019Project Grant

Principal investigators: Verma, Atul; Birnie, David H

Keywords: Atrial Fibrillation; Catheter Ablation; Oral Anticoagulation; Randomized Clinical Trial; Stroke Prevention

$100,000

The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) Trial

Nominated PICIHR2017Project Grant

Principal investigators: Verma, Atul; Birnie, David H

Keywords: Atrial Fibrillation; Catheter Ablation; Oral Anticoagulation; Randomized Clinical Trial; Stroke Prevention

$100,000

Planning meeting for a RCT grant on the treatment of AF in heart failure patients

Co-investigatorCIHR2010Planning Grants - Priority Announcement: Circulatory and Respiratory Health

Principal investigators: Tang, Anthony S

Keywords: Atrial Fibrillation; Heart Failure; Morbidity; Mortality; Randomized Controlled Trial

$19,488

A Randomized Ablation-based atrial Fibrillation rhythm control versus rate control Trial in patients with heart failure and high burden Atrial Fibrillation (RAFT-AF)

Principal investigatorCIHR2010Operating Grant

Principal investigators: Tang, Anthony S; Parkash, Ratika; Talajic, Mario; Verma, Atul; Wells, George A

Keywords: Atrial Fibrillation; Catheter Ablation; Heart Failure; Morbidity; Mortality; Multicentre; Optimal Medical Therapy; Randomized Controlled Trial

$4,941,966

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Medicine
Cardiology
School of Nursing
School of Epidemiology and Public Health
Department of Medicine
Other

Co-authors at University of Ottawa, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.

Sandra Lauck

School of Nursing

2 shared papers, latest 2023

George Wells

School of Epidemiology and Public Health

1 shared papers, latest 2012

Pablo Nery

Department of Medicine

1 shared papers, latest 2012

Amritanshu Pandey

Medicine

1 shared papers, latest 2017

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2020

Subject: Prospective PhD student: Atrial Fibrillation Dear Professor Verma, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Progression of Atrial Fibrillation after Cryoablation or Drug Therapy" (2023), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation (COAST-AF) Randomized Controlled Trial" (2020), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Atul Verma

Research

Latest papers

Latest funding

Progression of Atrial Fibrillation after Cryoablation or Drug Therapy

Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation

Real-world outcomes, complications, and cost of catheter-based ablation for atrial fibrillation: an update.

Subclinical Atrial Fibrillation in Older Patients

Long-term oral anticoagulation for patients after successful catheter ablation of atrial fibrillation: is it necessary?

Radiographic predictors of lead conductor fracture.

Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation

Clinical Predictors of Fidelis Lead Failure

Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation (COAST-AF) Randomized Controlled Trial

The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) Trial

The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) Trial

The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) Trial

Planning meeting for a RCT grant on the treatment of AF in heart failure patients

A Randomized Ablation-based atrial Fibrillation rhythm control versus rate control Trial in patients with heart failure and high burden Atrial Fibrillation (RAFT-AF)

Frequent collaborators

Vidal Essebag

Jeff Healey

Atul Verma

John Sapp

Laurent Macle

Sandra Lauck

Guy Amit

Vidal Essebag

John Sapp

Julia Cadrin-Tourigny

George Wells

Shamir Mehta

Ratika Parkash

Andrew Ha

Pablo Nery

Darryl Leong

William McIntyre

Amritanshu Pandey